Insilico Medicine
Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.
Company Facts
- Headquarters
- Cambridge
- Founded
- 2014
- Operating Status
- active
- Company Type
- for_profit
- IPO Status
- public
- Employees
- c_00101_00250
- Funding Stage
- ipo
- Total Funding
- $624,300,000
- Last Funding Type
- series_e
- Last Funding Date
- 2025-03-13
- Website
- http://www.insilico.com
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Health Care, Pharmaceutical
Social Links
Canonical: https://fsome.com/organization/insilico-medicine-58956 · For the full interactive profile (funding rounds, investors, team, portfolio, charts), please enable JavaScript.